(Q36357893)

13 August 2017

1 reference

title

Current approaches to diagnosis and treatment of invasive aspergillosis (English)

1 reference

13 August 2017

0 references

2

Thomas J Walsh

1 reference

13 August 2017

Brahm H Segal

1

1 reference

13 August 2017

language of work or name

English

0 references

publication date

30 December 2005

1 reference

American Journal of Respiratory and Critical Care Medicine

13 August 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

13 August 2017

volume

173

1 reference

13 August 2017

issue

7

1 reference

13 August 2017

page(s)

707-717

1 reference

Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Invasive mold infections in allogeneic bone marrow transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Stage-specific manifestation of mold infections in bone marrow transplant recipients: risk factors and clinical significance of positive concentrated smears.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: clinical, radiologic, and pathologic characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Investigation and control of aspergillosis and other filamentous fungal infections in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Outcome of lung transplantation in patients with mycetomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Pulmonary aspergillosis in the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Therapeutic outcome in invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Aspergillosis among people infected with human immunodeficiency virus: incidence and survival. Adult and Adolescent Spectrum of HIV Disease Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Invasive Aspergillus sinusitis in patients with human immunodeficiency virus infection. Report of 2 cases and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Aspergillus species colonization and invasive disease in patients with AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Long-term itraconazole prophylaxis against Aspergillus infections in thirty-two patients with chronic granulomatous disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Invasive aspergillosis in primary immunodeficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Itraconazole to prevent fungal infections in chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Comparison of Serum Galactomannan Antigen Detection and Competitive Polymerase Chain Reaction for Diagnosing Invasive Aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Rapid diagnosis of invasive aspergillosis by antigen detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Prospective screening by a panfungal polymerase chain reaction assay in patients at risk for fungal infections: implications for the management of febrile neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Diagnosis of invasive pulmonary aspergillosis using polymerase chain reaction-based detection of aspergillus in BAL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Efficacy of micafungin alone or in combination against systemic murine aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Assessing the antifungal activity and toxicity profile of amphotericin B lipid complex (ABLC; Abelcet) in combination with caspofungin in experimental systemic aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Combination antifungal therapy of murine aspergillosis: liposomal amphotericin B and micafungin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Combination antifungal therapy for invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Impact of previous aspergillosis on the outcome of bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Monocyte-macrophages, granulocyte-macrophage colony-stimulating factor, and prolonged survival among patients with acute myeloid leukemia and stem cell transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Use of macrophage colony-stimulating factor in the treatment of fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Selective effects of interleukin (IL)-15 on antifungal activity and IL-8 release by polymorphonuclear leukocytes in response to hyphae of Aspergillus species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Combination immunotherapy and antifungal chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Antifungal type 1 responses are upregulated in IL-10-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Cytokine- and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Interferon- and Tumor Necrosis Factor- Protect Mice from Invasive Aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

A Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

The safety of interferon-gamma-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

TLRs govern neutrophil activity in aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Liposomal amphotericin B activates antifungal resistance with reduced toxicity by diverting Toll-like receptor signalling from TLR-2 to TLR-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Anti-Aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Vaccinate against aspergillosis! A call to arms of the immune system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

T cell vaccination in mice with invasive pulmonary aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

A novel glyco-conjugate vaccine against fungal pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Prospects for dendritic cell vaccination against fungal infections in hematopoietic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Dendritic cell-based vaccination against opportunistic fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

The exploitation of distinct recognition receptors in dendritic cells determines the full range of host immune relationships with Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Novel strategies in antifungal lead discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Fungal infection in chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

The prospective evaluation of a nested polymerase chain reaction assay for the early detection of Aspergillus infection in patients with leukaemia or undergoing allograft treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-727SO

10.1164/RCCM.200505-727SO

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference